PSA Decline Is an Independent Prognostic Marker in Hormonally Treated Prostate Cancer

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.

William Kevin Kelly, Howard I. Scher, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1993 · 389 citations

Medicine, Oncology, Urology +13

Incidence of Prostate Cancer Diagnosis in the Eras Before and After Serum Prostate-Specific Antigen Testing

Steven J. Jacobsen · JAMA · 1995 · 231 citations

Medicine, Oncology, Urology +15

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

Jeffrey I. Miller, Frederick R. Ahmann, George W. Drach et al. · The Journal of Urology · 1992 · 169 citations

Medicine, Oncology, Urology +17

Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer

Yoichi Arai, Tatsuhiro Yoshiki, Osamu Yoshida · The Journal of Urology · 1990 · 122 citations

Medicine, Oncology, Urology +15

Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer

Haim Matzkin, Paul Eber, Barbara Todd et al. · Cancer · 1992 · 94 citations · Full text

Medicine, Oncology, Urology +17